Genocea Biosciences Appoints Adel Mahmoud and Robert Finberg to Scientific Advisory Board

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a vaccine discovery and development company, today announced the appointments of Adel Mahmoud, M.D., Ph.D. and Robert Finberg, M.D. to its Scientific Advisory Board. “With the addition of George Siber and now Adel Mahmoud, Genocea’s team boasts vaccine industry leaders who helped launch Wyeth’s Prevnar® and Merck’s Gardasil® and MMR®-II, some of the most commercially successful vaccines of all time,” said Robert Paull, co-founder and President of Genocea.

Back to news